Case report: ADHD and prognosis in tyrosinemia type 1
Neurometabolic disorders such as tyrosinemia type 1 (TYRSN1) may interfere with brain metabolism and show symptoms of attention-deficit hyperactivity disorder (ADHD) in patients treated with the enzyme inhibitor nitisinone [2-(2-nitro-4-trifluoromethylbenzoyl)-1,3-cyclohexanedione, NTBC]. It has bee...
Main Authors: | Helene Barone, Irene Bircow Elgen, Yngve Thomas Bliksrud, Eirik Vangsøy Hansen, Rita Rigmor Skavhellen, Magne Ivar Furevik, Jan Haavik |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2023-07-01
|
Series: | Frontiers in Psychiatry |
Subjects: | |
Online Access: | https://www.frontiersin.org/articles/10.3389/fpsyt.2023.1213590/full |
Similar Items
-
TYROSINEMIA TYPE III: A CASE REPORT OF SIBLINGS AND LITERATURE REVIEW
by: Fábio Barroso, et al. -
Genome Guided Personalized Drug Therapy in Attention Deficit Hyperactivity Disorder
by: Jan Haavik, et al.
Published: (2022-06-01) -
50 activities and games for kids with ADHD /
by: Quinn, Patricia O., et al.
Published: (2000) -
The science of ADHD : a guide for parents and professionals /
by: Chandler, Chris, 1966-
Published: (2011) -
Exploring ADHD : an ethnography of disorder in early childhood /
by: Bailey, Simon, 1978- author
Published: (2014)